Cargando…
Loss of HMGCS2 Enhances Lipogenesis and Attenuates the Protective Effect of the Ketogenic Diet in Liver Cancer
Hepatocellular carcinoma (HCC) is the most common primary malignant liver tumor with limited treatment. The ketogenic diet (KD) emerged as a metabolic therapy for cancer; however, the antitumor effect on HCC remains controversial. We previously reported that the ketogenesis rate-limiting enzyme, 3-h...
Autores principales: | Wang, Yuan-Hsi, Suk, Fat-Moon, Liao, Yi-Jen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408319/ https://www.ncbi.nlm.nih.gov/pubmed/32635582 http://dx.doi.org/10.3390/cancers12071797 |
Ejemplares similares
-
HMGCS2 Mediation of Ketone Levels Affects Sorafenib Treatment Efficacy in Liver Cancer Cells
por: Suk, Fat-Moon, et al.
Publicado: (2022) -
HMGCS2 Mediates Ketone Production and Regulates the Proliferation and Metastasis of Hepatocellular Carcinoma
por: Wang, Yuan-Hsi, et al.
Publicado: (2019) -
Ketogenic Diet Enhances the Cholesterol Accumulation in Liver and Augments the Severity of CCl(4) and TAA-Induced Liver Fibrosis in Mice
por: Liao, Yi-Jen, et al.
Publicado: (2021) -
Regulation of Ketogenic Enzyme HMGCS2 by Wnt/β-catenin/PPARγ Pathway in Intestinal Cells
por: Kim, Ji Tae, et al.
Publicado: (2019) -
HMGCS2 is a key ketogenic enzyme potentially involved in type 1 diabetes with high cardiovascular risk
por: Shukla, Sanket Kumar, et al.
Publicado: (2017)